We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$185M
AUM Growth
+$6.35M
Cap. Flow
-$4.39M
Cap. Flow %
-2.37%
Top 10 Hldgs %
41.23%
Holding
94
New
5
Increased
11
Reduced
47
Closed
4

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$3.93M
2
ACN icon
Accenture
ACN
+$492K
3
COF icon
Capital One
COF
+$275K
4
APA icon
APA Corp
APA
+$109K
5
PM icon
Philip Morris
PM
+$67.8K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.7M
2
COO icon
Cooper Companies
COO
+$1.02M
3
STZ icon
Constellation Brands
STZ
+$769K
4
AAPL icon
Apple
AAPL
+$397K
5
EXAS
Exact Sciences
EXAS
+$317K

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Industrials 19.83%
3 Financials 19.25%
4 Healthcare 14.29%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEHC icon
51
GE HealthCare
GEHC
$30.7B
$735K 0.4%
9,926
-399
-4% -$27.8K
KR icon
52
Kroger
KR
$35.4B
$717K 0.39%
10,000
– –
NVDA icon
53
NVIDIA
NVDA
$4.86T
$711K 0.38%
4,500
+230
+5% +$28.9K
VZ icon
54
Verizon
VZ
$195B
$709K 0.38%
16,383
– –
VLTO icon
55
Veralto
VLTO
$23B
$705K 0.38%
6,980
-175
-2% -$16.9K
APA icon
56
APA Corp
APA
$13.2B
$541K 0.29%
29,590
+6,300
+27% +$109K
MCD icon
57
McDonald's
MCD
$192B
$509K 0.28%
1,743
– –
JPM icon
58
JPMorgan Chase
JPM
$935B
$483K 0.26%
1,665
– –
FFIV icon
59
F5
FFIV
$22.9B
$446K 0.24%
1,515
+200
+15% +$55.3K
PANW icon
60
Palo Alto Networks
PANW
$270B
$409K 0.22%
2,000
– –
HD icon
61
Home Depot
HD
$331B
$374K 0.2%
1,020
– –
BAX icon
62
Baxter International
BAX
$13.5B
$358K 0.19%
11,835
– –
FTV icon
63
Fortive
FTV
$17.9B
$327K 0.18%
6,266
-2,529
-29% -$132K
COF icon
64
Capital One
COF
$128B
$314K 0.17%
+1,474
New +$275K
PEP icon
65
PepsiCo
PEP
$190B
$310K 0.17%
2,345
– –
CSCO icon
66
Cisco
CSCO
$457B
$302K 0.16%
4,359
– –
PG icon
67
Procter & Gamble
PG
$336B
$295K 0.16%
1,850
– –
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.1T
$294K 0.16%
605
– –
KLAC icon
69
KLA
KLAC
$239B
$269K 0.15%
3,000
– –
AMTM
70
Amentum Holdings
AMTM
$5.42B
$264K 0.14%
11,202
-172
-2% -$3.6K
XOM icon
71
ExxonMobil
XOM
$644B
$253K 0.14%
2,343
– –
ABT icon
72
Abbott
ABT
$183B
$235K 0.13%
1,730
– –
MA icon
73
Mastercard
MA
$502B
$203K 0.11%
361
– –
SOBO
74
South Bow Corp
SOBO
$7.74B
$195K 0.11%
10,269
-218
-2% -$5.55K
NFLX icon
75
Netflix
NFLX
$299B
$187K 0.1%
1,400
– –
1 2
3
4

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Lipe & Dalton's Q2 2025 Portfolio in Review

As of Q2 2025, Lipe & Dalton held 94 positions worth $185M, up 3.6% from $179M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Lipe & Dalton's Q2 2025 filing shows 5 new, 11 increased, 47 reduced and 4 closed positions. Its largest new stake was Thermo Fisher Scientific: 9,404 shares worth $3.81M. The largest sale was Bristol-Myers Squibb, an estimated $2.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

  • Lipe & Dalton's largest Q2 2025 buy was Thermo Fisher Scientific: 9,404 shares worth $3.81M.
  • Lipe & Dalton added most to Accenture in Q2 2025, an estimated $492K increase.
  • Lipe & Dalton's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $2.7M.
  • Lipe & Dalton fully exited Cooper Companies in Q2 2025, selling an estimated $1.02M.
  • Lipe & Dalton's ten largest holdings make up 41% of its $185M portfolio in Q2 2025.
  • Lipe & Dalton opened 5 new positions and closed 4 in Q2 2025.
  • Lipe & Dalton's portfolio value rose 3.6% quarter-over-quarter to $185M.

Based on Lipe & Dalton's 13F filing for Q2 2025, filed 1 Aug 2025.